Osborne Clarke advises MAP Group on the acquisition of SKC

Osborne Clarke has advised MAP Group, a portfolio company of private equity firm Kester Capital, on the acquisition of SKC Beratungsgesellschaft mbH.

MAP Group, an international strategy consultancy focused on pharmaceutical and biotechnology companies, advises its clients on accessing Europe's complex medical regulatory and payer environment. Through specialised consulting products and services, as well as an online platform that provides companies with access to expert knowledge, the distribution of innovative healthcare solutions in Europe is enabled. MAP Group is headquartered in the United Kingdom and has additional locations across Europe, from where it offers its product and service portfolio to clients worldwide, supported by Kester Capital.

MAP Group has now acquired SKC Beratungsgesellschaft mbH, based in Hanover. Founded in 2005, SKC is a leading German strategy consultancy for complex issues in the areas of market access, pricing, and reimbursement of innovative medicines (AMNOG), medical devices, and digital health applications (DiGA).

The SKC founding team, Dr Matthias P. Schönermark and Heike Kielhorn-Schönermark, will join the executive leadership team of MAP Group. The acquisition aims to expand the range of offerings and geographic reach.

“With the addition of the experienced and talented team from SKC, we advance our objective to ensure patient access to life-changing therapies in Europe and beyond,” said Steve Glass, CEO of MAP Group.

The Osborne Clarke team, which advised MAP Group under the lead of Lorenz Chwaszcza and Dr Nanni Spitzer (Partner responsibility), consisted of Philip Meichssner (all Corporate / M&A), Julia Kaufmann, Dr Florian Eisenmenger (both Data Protection), André Braig, Leonie Madlener, Eva Althof (all Employment), Dr Tim Reinhard, Tamara Giebisch (both IP), Florian Merkle, Tim Florian Metzmeier, Patrick Seiler (all Tax), Dr Birgit Schmeyer (Commercial) and Laura Valeske (Legal Project Management).

The German team was supported by Osborne Clarke UK, namely Pippa Byrne, George Baker Baker (both M&A, Corp. Finance and PE), Elizabeth Shanahan and Helena Zaba (both Tax).